Climbing NASDAQ Stocks: Endocyte, Inc.(NASDAQ:ECYT), Array Biopharma Inc(NASDAQ:ARRY), and Orexigen Therapeutics, Inc.(NASDAQ:OREX)
New York, NY – 09/24/2014 – HotStockGains provides investors and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.
Endocyte, Inc.(NASDAQ:ECYT) gained twenty-one cents to reach a new closing price of $7.20, a 3% increase in value from the previous mark recorded on Sept. 22nd. The stock has traded within a range of $5.91 to $33.70 over the past 52 weeks. On Monday afternoon, Endocyte, Inc.(NASDAQ:ECYT) announced that it would be making an oral presentation at the European Society for Medical Oncology on Sept. 27th. The stock gained five cents during after-hours trading.
Array Biopharma Inc(NASDAQ:ARRY) saw its value increase by 2.74% yesterday as the stock gained ten cents to move to a closing price of $3.75. The stock has traded within a range of $3.39 to $6.66 over the past 52 weeks. Array Biopharma Inc(NASDAQ:ARRY) currently has a bid price of $3.60 x 3,000 and an offer price of $4.18 x 500. The company currently has a market capitalization of $481.17 million and 131.83 million tradeable shares.
Orexigen Therapeutics, Inc.(NASDAQ:OREX) enjoyed a fifteen cent gain yesterday as the stock reached a new closing price of $4.66. The 3.33% increase in value places the stock thirty-four cets above its 52 week low of $4.32. To contrast, Orexigen Therapeutics, Inc.(NASDAQ:OREX) is currently situated $3.16 below its 52 week high of $7.82. The California-based biopharmaceutical company, which develops drug candidates for the treatment of obesity, has a market capitalization of $552.63 million and 122.53 million tradeable shares.
I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.
I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.
Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.